Given that Efa up-regulates the expression of IL-8 and VEGFA in CRC cells, and that the conditioned medium of Efa promotes the viability of CRC cells, it can be hypothesized that Efa may perform this function through its metabolites. The gene discussed is VEGFA; the disease is colorectal carcinoma.